[Congressional Record Volume 162, Number 44 (Monday, March 21, 2016)]
[Extensions of Remarks]
[Page E341]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]




  CONGRATULATIONS TO THE JOHNS HOPKINS BLOOMBERG-KIMMEL INSTITUTE FOR 
                          CANCER IMMUNOTHERAPY

                                 ______
                                 

                            HON. MARK TAKAI

                               of hawaii

                    in the house of representatives

                         Monday, March 21, 2016

  Mr. TAKAI. Mr. Speaker, I would like to take this time to recognize 
the establishment of the Johns Hopkins Bloomberg-Kimmel Institute for 
Cancer Immunotherapy. I personally look forward to all of the 
innovative programs that they will establish and the lives they will 
save. This cutting-edge treatment will revolutionize cancer treatment. 
This form of medicine works to harness the body's existing immune 
system to destroy cancerous cells, without harming healthy ones, as an 
effective treatment against nearly all solid tumors.
   This year funding for the National Institutes of Health was $32.1 
billion, a $2 billion increase over the year before. This increase is 
in no small part due to the diligence and perseverance of Vice 
President Biden who is spearheading the White House's Cancer Moonshot. 
Increased funding in cancer research will allow for more research into 
precision medicine programs, which will help develop even more 
personalized technologies expand their reach. I know this generation 
can be the one to cure cancer, and it is due to outstanding research 
institutions such as the Johns Hopkins Bloomberg-Kimmel Institute for 
Cancer Immunotherapy.
   Once again, I would like to thank Johns Hopkins for their commitment 
to fighting cancer and congratulate them on the establishment of this 
new center. I look forward to witnessing their important strides and 
breakthroughs in the field of cancer research. Thank you (Mahalo).

                          ____________________